Navigation Links
Strong Demand Pushes up Both Prices and Sales Volumes for Dragon's Main Products
Date:10/3/2007

VANCOUVER, Oct. 3 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. (TSX: DDD; OTCBB: DRUG; BBSE: DRP) today announces major increase in both prices and sales volumes for its main products. Further, under favorable market conditions, the Company has been operating near its maximum capacity to meet rising customer demand.

During the first eight months ended August 31, 2007, the Company has achieved significant increase in both price and sales volume for its main product 7ACA. The market price for 7ACA in China, including value added tax, has risen 27%, from 750 RMB/kg in January 2007 to 950 RMB/kg in August 2007, representing a record high price for the past two years. Total sales quantity of 7ACA reached 360 tons, an increase of 38% compared with 261 tons of sales for the same period of 2006.

The prime reason for the increase is because the rising demand for 7ACA has exceeded supplies. On one hand, the Chinese Government's effort to expand its National Medical Coverage in the rural area has triggered a strong demand for the basic antibiotic drugs; on the other hand, export from China continues to increase as other international 7ACA manufacturers outside of China continue to curtail their production levels. China is noted for its low cost and large-scale production of active pharmaceutical ingredients (APIs), and has fast emerged as a powerful player in the global API market with an average growth rate exceeding 25%. Meanwhile, since the prices of Penicillin intermediates still remain high, many customers have purchased cephalosporins as alternatives, which has further pushed up the demand for 7ACA products. During the first eight months of 2007, Dragon has maintained a utilization rate of over 90% for its production facility, compared to approximately 67% for the same period in 2006, in order to keep up with the demand from its existing and new customers.

Another factor affecting the price of 7ACA is the increased cost of raw materials, e
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lance Armstrong and the future of cancer care
2. Entrepreneurship grant will build strong foundation
3. Corporate control begins with a strong board
4. Midwest colleges strong contenders for NIH funds
5. Fiserv reports stronger earnings and revenues
6. Third Wave reports another loss, stronger sales
7. Is Wisconsins economy stronger, weaker, or just changing?
8. Third coast of biotechnology makes strong showing at VC conference
9. Fiserv Reports Strong Earnings for Third Quarter of 2005
10. UWs Waisman Center seeing strong demand for biomanufacturing facility time
11. Midwest holds strong position in worldwide diagnostics business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... A novel robotic system that can operate ... being tested as part of a biomedical research partnership ... the aim of determining if the robot, in conjunction ... faster, more accurate, less costly, and less discomforting for ... to deliver prostate cancer therapies with greater precision. , ...
(Date:9/18/2014)... Texas (PRWEB) September 18, 2014 ... Chancellor John Sharp, Texas A&M Health Science Center ... U.S. Department of Health and Human Services (HHS), ... dedicated a national pandemic influenza vaccine manufacturing facility ... as an anchor for the Texas A&M Biocorridor ...
(Date:9/18/2014)... Sept. 18, 2014 Research and ... "Global N-acetylcysteine Industry Report 2014" report ... N-acetylcysteine Industry Report 2014 is a professional and ... global N-acetylcysteine industry. The report provides ... classifications, applications and industry chain structure. The N-acetylcysteine ...
(Date:9/18/2014)... September 18, 2014 Leatherwood Plastics ... listed material, to stay competitive in the semiconductor, ... high-performance materials ultimately impact product quality and productivity, ... owner. , Established in 1980 in Lewisville, TX, ... many fabricators have left the business. Much of ...
Breaking Biology Technology:Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 4Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 5Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 6Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4Global N-acetylcysteine Industry Report 2014 2Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2
... (Nasdaq: PBIO ) ("PBI" or the "Company") today ... was $334,041 compared to $174,071 for the comparable period in ... PCT products and services was $233,256 for the three months ... period in 2007, a 97% increase. During the fourth ...
... 4 Tigris Pharmaceuticals, Inc., a privately held ... New Drug (IND) application for the Company,s geranylgeranyltransferase ... Food and Drug Administration. This will allow the ... the safety of GGTI-2418 during the first quarter ...
... Head of Nektar Therapeutic,s Pulmonary Business Unit, Among ... Savara, Inc., a biopharmaceutical company developing novel ... today announced that it has expanded its Board ... Elam, former head of the pulmonary business unit ...
Cached Biology Technology:Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 2Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 3Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 4Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 5Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 6Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 7Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008 8FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceutical's GGTI-2418 2Savara Expands Board of Directors, Appoints Three New Members 2Savara Expands Board of Directors, Appoints Three New Members 3
(Date:9/18/2014)... several disciplines will be celebrated tonight at the third ... improving the health of premature infants and in paving ... researchers, whose work was supported by the National Science ... Atomic Energy Commission, will be honored at a ceremony ... bipartisan group of Members of Congress will be on ...
(Date:9/18/2014)... cycles of carbon and nitrogen comprise all spheres ... environmental systems have caused imbalances and perturbations that ... (GHGs). Increased GHGs result in climate changes which ... oceans and the atmosphere. Understanding these feedback mechanisms ... of environmental science during the past three decades. ...
(Date:9/18/2014)... are too stressed they are often grouchy, grumpy, nasty, ... (BMI) at EPFL have just highlighted a fundamental synaptic ... the loss of social skills and cognitive impairment. When ... molecule in the brain. This was revealed by a ... Carmen Sandi,s team went to look for answers in ...
Breaking Biology News(10 mins):3rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2Greenhouse gas research enters a new era 2How stress tears us apart 2
... looking good for him. Up until now he has been in ... he finishes first is often decided by just a few seconds. ... on the cross-country ski run, the condition of the athlete on ... Olympic skiing stars who are wooed by sponsors, up until now ...
... that celiac disease is increasing in prevalence because farmers are ... conclusion of an article in the ACS, Journal of ... evidence that the incidence of celiac disease increased during the ... the disease is 4 times more common today. Also known ...
... Michael Pogue, a Research Entomologist in the ARS ... , Washington, DC, was sent a series of moth ... under consideration as a possible biocontrol agent for the ... species was initially identified as a common species, but ...
Cached Biology News:Optimized custom-made ski sledges 2Optimized custom-made ski sledges 3Biocontrol research on Brazilian peppertree in Florida discovers new cryptic species 2